🔎 Trials Near Me

Home › Myasthenia Gravis › District of Columbia

Pag-aaral pangklinika para sa Myasthenia Gravis sa District of Columbia

6 pag-aaral para sa Myasthenia Gravis ang naghahanap ng mga kalahok sa mga site sa District of Columbia.

Mga Lungsod sa District of Columbia

Opisyal na teksto ng pag-aaral (English)

Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

  • The George Washington University, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07787247

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  • The George Washington University Medical Faculty Associates Foggy Bottom South Pavilion, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06463587

MuSK Myasthenia 1000 Study

  • George Washington University, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 7 hanggang 99 · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06259071

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1024, Washington D.C.
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07039916

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

  • Research Site, Washington D.C.
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT06607627

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  • Clinical Trial Site, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT04202341

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.